Logo - springer
Slogan - springer

Medicine - Oncology & Hematology | Journal for ImmunoTherapy of Cancer

Journal for ImmunoTherapy of Cancer

Journal for ImmunoTherapy of Cancer

Editor-in-Chief: Pedro Romero

ISSN: 2051-1426 (electronic version)

Journal no. 40425

BioMed Central

Open access BioMed Central
 Learn more about the metrics of this journal
  • The official journal of the Society for ImmunoTherapy of Cancer (SITC)
  • Free article processing charges for SITC members
  • Distributed to over 15,000 individuals in the cancer treatment space and downloaded more than 800,000 times in 2015

Journal for ImmunoTherapy of Cancer (JITC) is the premiere cancer immunotherapy journal at BMC, , and the official journal of the Society for Immunotherapy of Cancer (SITC). JITC welcomes basic, translational and clinical research and literature reviews on any aspect of tumor immunology and cancer immunotherapy. Topics of interest include tumor-host interactions, immune biomarkers, novel therapeutics, and immune-related toxicity.  The journal’s full collection, including its seminal guidelines and consensus statements, advances the rapidly evolving field of cancer immunotherapy through dissemination of rigorous peer-reviewed research.

Related subjects » Immunology - Oncology & Hematology

Impact Factor: 8.374 (2017) * 

Journal Citation Reports®

Abstracted/Indexed in 

Science Citation Index Expanded (SciSearch), Journal Citation Reports/Science Edition, Medline, PubMedCentral, SCOPUS, EMBASE, Google Scholar, CNKI, DOAJ, EBSCO Academic Search, EBSCO Discovery Service, EBSCO TOC Premier, OCLC WorldCat Discovery Service, ProQuest-ExLibris Primo, ProQuest-ExLibris Summon, Reaxys

Read This journal on BioMed Central

For authors and editors

  • Journal Citation Reports®
    2017 Impact Factor
  • 8.374
  • Aims and Scope

    Aims and Scope


    Journal for ImmunoTherapy of Cancer is an open access, peer reviewed journal that encompasses all aspects of tumor immunology and cancer immunotherapy, from basic research through to clinical applications.

    The journal welcomes submissions in the following sections and other related topics:

    • Basic Tumor Immunology - edited by Cornelis J. Melief
    • Case Reports - edited by Alfred Zippelius
    • Clinical Trials Monitor - edited by Leisha A. Emens
    • Clinical/Translational Cancer Immunotherapy - edited by James L. Gulley
    • Commentary/Editorials - edited by Christian Capitini
    • Guidelines and Consensus Statements – edited by Robert L. Ferris
    • Immunotherapy Biomarkers - edited by Lisa H. Butterfield
    • Reviews - edited by Sandra Demaria and Thomas F. Gajewski
  • Submit Online
  • Writing Resources: Training for Authors

Alerts for this journal


Get the table of contents of every new issue published in Journal for ImmunoTherapy of Cancer.